WO2018098935A1 - Vector for plant genome site-directed base substitution - Google Patents

Vector for plant genome site-directed base substitution Download PDF

Info

Publication number
WO2018098935A1
WO2018098935A1 PCT/CN2017/077133 CN2017077133W WO2018098935A1 WO 2018098935 A1 WO2018098935 A1 WO 2018098935A1 CN 2017077133 W CN2017077133 W CN 2017077133W WO 2018098935 A1 WO2018098935 A1 WO 2018098935A1
Authority
WO
WIPO (PCT)
Prior art keywords
plant
expression cassette
vector
construct
cell
Prior art date
Application number
PCT/CN2017/077133
Other languages
French (fr)
Chinese (zh)
Inventor
朱健康
陆钰明
Original Assignee
中国科学院上海生命科学研究院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国科学院上海生命科学研究院 filed Critical 中国科学院上海生命科学研究院
Publication of WO2018098935A1 publication Critical patent/WO2018098935A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8205Agrobacterium mediated transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8206Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
    • C12N15/8207Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated by mechanical means, e.g. microinjection, particle bombardment, silicon whiskers

Definitions

  • the present invention relates to the field of biotechnology, and in particular to a vector for site-based base substitution of a plant genome and a method for site-based base substitution of a plant genome.
  • Zinc finger nuclease Zinc finger nuclease
  • TAL transcription activator-like effector nucleases
  • CRISPR/Cas9 technologies are several breakthroughs in the field of genome editing in recent years.
  • Sexual techniques 1-3 All three techniques can generate double-strand breaks in a specific site-specific cleavage DNA in an organism's genome, thereby performing site-directed editing using non-homologous end joining or homologous recombination of the organism.
  • the ZFN and Talen technologies are guided by specific proteins, the construction of protein components is relatively complicated, and the editing efficiency needs to be improved.
  • the CRISPR/Cas9 technology is guided by RNA, which is simple to construct in vitro and has high editing efficiency.
  • three techniques have been successfully applied to a variety of organisms, including E. coli, yeast, rice, Arabidopsis, soybean, corn, and other four mice and human cells.
  • the object of the present invention is to provide an efficient fixed-point base replacement tool suitable for plant cells. And stable plants can be obtained, which can be effectively applied to plant research and breeding.
  • a first aspect of the invention provides a nucleic acid construct for genetically editing a plant, the nucleic acid construct comprising:
  • the first expression cassette is a gRNA expression cassette for expressing gRNA
  • the second expression cassette is a fusion protein expression cassette for expression of a fusion protein having the structure of Formula Ia or Ib:
  • A is a cytosine deaminase
  • L1 is no or the first linker peptide (such as Xten)
  • B is Cas9 without cleavage activity or Cas9 having only single-strand cleavage activity
  • L2 is a no or second linker peptide (such as Xten);
  • U Uracil DNA glycosylase inhibitor
  • the third expression cassette is a selection marker expression cassette for expressing a selection marker
  • first expression cassette, the second expression cassette, and the third expression cassette are each independently located on the same or different carriers.
  • the first expression cassette has the structure of formula A:
  • X1 is a plant promoter, preferably a plant polymerase III driven promoter (such as U6, U3 promoter);
  • X2 is the coding sequence of gRNA
  • X3 is polyT.
  • the second expression cassette has the structure of formula B:
  • Y1 is a plant promoter, preferably UBI, CaMV35S, Actin promoter;
  • Y2 is the coding sequence of a fusion protein having the structure of formula Ia or Ib as described above;
  • Y3 is a terminator
  • the third expression cassette has the structure of formula C:
  • Z1 is a plant promoter, preferably a 35S, UBI, Actin promoter;
  • Z2 is a coding sequence encoding a screening marker
  • Z3 is the terminator.
  • the selection marker is selected from the group consisting of a hygromycin resistance gene (HYG), a G418 and kanamycin resistance gene (NPTII), and a Basta resistance gene (BAR). , puromycin resistance gene (PAC), neomycin resistance gene (NEO), or a combination thereof.
  • HAG hygromycin resistance gene
  • NPTII G418 and kanamycin resistance gene
  • BAR Basta resistance gene
  • PAC puromycin resistance gene
  • NEO neomycin resistance gene
  • first expression cassette and the second expression cassette are located on the same carrier.
  • first expression cassette, the second expression cassette, and the third expression cassette are located on the same carrier.
  • the second expression cassette and the third expression cassette are located on the same carrier.
  • the vector is an expression vector that can be transfected or transformed into a plant cell.
  • the carrier is an Agrobacterium Ti carrier.
  • the two or three expression cassettes are arranged in clusters. Thereby an expression cassette is constructed.
  • the RB sequence is contained outside the 5' end of the expression cassette, and the LB sequence is contained outside the 3' end of the expression cassette.
  • the order of arrangement of each expression cassette is selected from the group consisting of:
  • first expression cassette and the second expression cassette are located on different vectors.
  • the RB sequence is contained outside the 5' end of the expression cassette; and the LB sequence is contained outside the 3' end of the expression cassette.
  • a second aspect of the invention provides an expression vector comprising the nucleic acid construct of the first aspect of the invention, wherein the first expression cassette, the second expression cassette, and the third expression cassette They are each independently located on the same or different carriers.
  • the expression vector backbone is pCamiba1300.
  • the vector is an expression vector that can be transfected or transformed into a plant cell.
  • the carrier is an Agrobacterium Ti carrier.
  • the carrier is cyclic or linear.
  • a third aspect of the invention provides a host cell comprising the expression vector of the second aspect of the invention.
  • the host cell is Agrobacterium.
  • the host cell is a plant cell.
  • a fourth aspect of the invention provides a genetically engineered cell comprising the construct of the first aspect of the invention, or a genome thereof integrated with one or more of the constructs of the first aspect of the invention.
  • the cell is a plant cell.
  • the plant is selected from the group consisting of a gramineous plant, a leguminous plant, a cruciferous plant, or a combination thereof.
  • the plant is selected from the group consisting of rice, soybean, tomato, corn, tobacco, wheat, sorghum, Arabidopsis thaliana, barley, oats, millet, peanuts, or combinations thereof.
  • the genetically engineered cell is introduced into the cell by the method according to the first aspect of the invention by a method selected from the group consisting of Agrobacterium transformation, gene gun, microinjection, and electric shock. Method, ultrasonic method, polyethylene glycol (PEG) mediated method, or a combination thereof.
  • a fifth aspect of the invention provides a method for genetically editing a plant, comprising the steps of:
  • the introduction is introduced by Agrobacterium.
  • the introduction is by a gene gun.
  • the gene is edited as a fixed-point base substitution.
  • the site-directed mutagenesis comprises mutating C to T or C to G
  • the site-directed mutagenesis comprises site-directed mutagenesis of C in positions 4-8 of the distal end of the PAM.
  • a sixth aspect of the invention provides a method of preparing a transgenic plant cell, comprising the steps of:
  • the transfection is performed using an Agrobacterium transformation method or a gene gun bombardment method.
  • a seventh aspect of the invention provides a method of preparing a transgenic plant cell, comprising the steps of:
  • An eighth aspect of the invention provides a method of preparing a transgenic plant, comprising the steps of:
  • the transgenic plant cell prepared by the method of the sixth aspect of the invention or the method of the seventh aspect of the invention is regenerated into a plant body, thereby obtaining the transgenic plant.
  • a ninth aspect of the invention provides a transgenic plant, which is prepared by the method of the eighth aspect of the invention, or the plant cell of the plant comprises the construct of the first aspect of the invention or The genome is integrated with one or more of the constructs of the first aspect of the invention.
  • Figure 1 is a schematic diagram of site-based base substitution based on cytosine deaminase.
  • the DNA sequence expressing Cas is ligated to a DNA sequence expressing cytosine deaminase, transformed into a plant receptor, and the DNA in the transformed plant cell expresses the fusion protein and guide RNA.
  • Figure 2 uses a fixed-base replacement vector of APOBEC1 and CRISPR/Cas9.
  • A Schematic representation of the vector pCSGAPO1.
  • B Schematic diagram of the deamination region.
  • FIG. 1 Results of fixed-base substitution of rice callus.
  • A Schematic diagram of base substitution of rice NRT1.1B gene.
  • B Schematic diagram of base substitution of rice SLR1 gene.
  • C High-throughput sequencing results.
  • FIG. 1 Base substitution results of the NRT1.1B gene in rice transgenic plants.
  • A Sanger sequencing results of Indel plants (#35) and base replacement plants (#15).
  • B Single colony sequencing results of PCR products of base replacement plants (#15).
  • Figure 5 shows the results of base substitution of the SLR1 gene in rice transgenic plants.
  • A Schematic and results of StyI digestion assay.
  • B Sanger sequencing results of Indel plants (#07) and base substitution plants (#07, #10, #18, #23, #28, and #37).
  • C Single colony sequencing results of base replacement plants (#07).
  • D T0 generation plant phenotype of wild type (WT), knockout (SLR#09) and base substitution (SLR#07) of SLR1 gene.
  • the present inventors have extensively and intensively studied to screen out optimized promoters for specific sites by extensive screening, and by using a nucleic acid construct of a specific structure, the present invention successfully achieves RNA-directed bases in plants for the first time.
  • Site-directed mutagenesis (such as C mutation to T or G), and mutation efficiency can be as high as 11.5%, and up to 60% of cells in a mutant plant have been replaced.
  • the present invention finds for the first time that cytosine deaminase can cleave the cytosine on the target genome of a plant cell under the guidance of CRISPR/Cas9, mutate it to T or G, and complete on this basis.
  • the invention has been made.
  • base substitution base mutation
  • base mutation are used interchangeably and refer to the mutation of a base to another base, such as a C mutation to T or a C mutation to G.
  • screening marker gene refers to a gene used for screening a transgenic cell or a transgenic animal in a transgenic process
  • the screening marker gene useful in the present application is not particularly limited, and includes various screening marker genes commonly used in the transgenic field, representative examples. Including (but not limited to): hygromycin resistance gene (Hyg), kanamycin resistance gene (NPTII), neomycin gene, puromycin resistance gene, hygromycin resistance gene (HYG , G418 and kanamycin resistance gene (NPTII), Basta resistance gene (BAR), puromycin resistance gene (PAC), and/or neomycin resistance gene (NEO).
  • Hyg hygromycin resistance gene
  • NPTII kanamycin resistance gene
  • NPTII kanamycin resistance gene
  • NPTII puromycin resistance gene
  • BAR Basta resistance gene
  • PAC puromycin resistance gene
  • NEO neomycin resistance gene
  • the term "expression cassette” refers to a stretch of polynucleotide sequences comprising a gene to be expressed and a sequence component that expresses the desired element.
  • the term “screening marker expression cassette” refers to a polynucleotide sequence comprising a sequence encoding a selection marker and a sequence component expressing the desired element.
  • the components required for expression include a promoter and a polyadenylation signal sequence.
  • the selection marker expression cassette may or may not contain other sequences including, but not limited to, enhancers, secretion signal peptide sequences, and the like.
  • the promoter suitable for the exogenous gene expression cassette and the selection marker gene expression cassette may be any of the common promoters, and it may be a constitutive promoter or an inducible promoter.
  • the promoter is a constitutive promoter, such as a UBI promoter, and other plant promoters suitable for eukaryotic expression.
  • plant promoter refers to a nucleic acid sequence capable of initiating transcription of a nucleic acid in a plant cell.
  • the plant promoter may be derived from a plant, a microorganism (such as a bacterium, a virus) or an animal, or a synthetic or engineered promoter.
  • plant terminator refers to a terminator capable of stopping transcription in a plant cell.
  • the plant transcription terminator may be derived from a plant, a microorganism (such as a bacterium, a virus) or an animal, or a synthetic or engineered terminator. Representative examples include (but are not limited to): Nos terminator.
  • Cas protein refers to a nuclease.
  • a preferred Cas protein is the Cas9 protein.
  • Typical Cas9 proteins include, but are not limited to, Cas9 derived from Streptococcus pyogenes.
  • the Cas9 protein is a mutated Cas9 protein, specifically, a mutant Cas9 protein having no cleavage activity or only single-strand cleavage activity.
  • the term "coding sequence of a Cas protein” refers to a nucleotide sequence that encodes a Cas protein.
  • the skilled artisan will recognize that because of the degeneracy of the codon, a large number of polynucleotide sequences can encode the same polypeptide. .
  • the skilled person will also recognize that different species have a certain preference for codons, and may optimize the codons of the Cas protein according to the needs of expression in different species. These variants are all referred to by the term "Cas protein.
  • the coding sequence is specifically covered.
  • the term specifically encompasses a full-length sequence substantially identical to the Cas gene sequence, as well as a sequence encoding a protein that retains the function of the Cas protein.
  • plant includes whole plants, plant organs (such as leaves, stems, roots, etc.), seeds and plant cells, and progeny thereof.
  • the kind of plant which can be used in the method of the present invention is not particularly limited, and generally includes any higher plant type which can be subjected to transformation techniques, including monocots, dicots, and gymnosperms.
  • nucleic acid construct for gene editing of a plant comprising:
  • the first expression cassette is a gRNA expression cassette for expressing gRNA
  • the second expression cassette is a fusion protein expression cassette for expression of a fusion protein having the structure of Formula Ia or Ib:
  • A is a cytosine deaminase
  • L1 is no or the first linker peptide (such as Xten)
  • B is Cas9 without cleavage activity or Cas9 having only single-strand cleavage activity
  • L2 is a no or second linker peptide (such as Xten);
  • U Uracil DNA glycosylase inhibitor
  • the third expression cassette is a selection marker expression cassette for expressing a selection marker
  • first expression cassette, the second expression cassette, and the third expression cassette are each independently located on the same or different carriers.
  • the construction of the present invention is carried out by inserting the construct of the present invention into an exogenous vector, especially a vector suitable for transgenic plant manipulation.
  • the transgenic plant cells are prepared by transforming the vector of the present invention into plant cells to mediate the integration of the plant cell chromosomes by the vector of the present invention.
  • transgenic plant cells of the present invention are regenerated into plant bodies to obtain transgenic plants.
  • the above nucleic acid construct constructed by the present invention can be introduced into a plant cell by a conventional plant recombination technique (for example, Agrobacterium transfer technology) to obtain a nucleic acid construct (or a vector carrying the nucleic acid construct). Plant cells, or plant cells in the genome in which the nucleic acid construct is integrated.
  • a conventional plant recombination technique for example, Agrobacterium transfer technology
  • the main feature of this vector is the linkage of cytosine deaminase to the Cas protein in the CRISPR/Cas system to form a fusion protein, which is directed by the guide RNA to a target site in the genome. Since cytosine deaminase directly deacetylates cytosine C to form U, DNA double-strand cleavage activity of Cas protein is not required. Therefore, in the present invention, the Cas protein is a mutant Cas protein having no cleavage activity. After deamination of cytosine C to form U, plant cells initiate base mismatch repair and repair U-G to T-A or C-G.
  • the DNA single-strand nicking activity of the Cas protein can be retained, that is, the single-strand nicking is caused in the non-edited single strand (editing the matching strand of the target C). Therefore, preferably, the cytosine deaminase is fused to a Cas protein having single-strand nicking activity to form a fusion protein.
  • the proteins are usually linked by some flexible short peptides, namely Linker.
  • the Linker can use XTEN.
  • a strong promoter suitable for plant cells such as the CaMV 35S promoter or the UBI promoter, is generally selected.
  • the expression cassette of the guide RNA suitable for plant cells is selected and constructed in the same vector as the fusion protein expression cassette described above. Obviously, these two expression cassettes can also be on different DNA molecules.
  • the region of action of the deaminase is generally fixed.
  • the deamination region is the 4-8 base region of the guilde RNA, which is Amino window area" ( Figure 2).
  • the cytosine to be edited is in the "deamination window" when designing the target.
  • the above vector is introduced into a plant recipient by a suitable method.
  • the introduction methods include, but are not limited to, gene gun method, microinjection method, electric shock method, ultrasonic method, and polyethylene glycol (PEG)-mediated method.
  • Receptor plants include, but are not limited to, rice, soybean, tomato, corn, tobacco, wheat, sorghum, and the like.
  • the DNA in the transformed plant cell expresses the fusion protein and the guide RNA.
  • the Cas protein fused with cytosine deaminase, under the guidance of its guide RNA, deamination of cytosine C at the target site to uracil U, and then repairs U to T or G under the action of the plant cell repair system. Further, the plants after base substitution are obtained by tissue culture.
  • the invention can be used in the field of plant genetic engineering for plant research and breeding, especially genetic improvement of economically valuable crops and forestry crops.
  • the present invention provides, for the first time, an efficient method for realizing site-directed base mutations in plants, which can be widely used for plant research and breeding.
  • the method of site-directed base mutation of the present invention can efficiently perform base mutation (e.g., C mutation to T or G) at a specific position of a plant cell.
  • base mutation e.g., C mutation to T or G
  • the method of the present invention can effectively avoid random integration of foreign DNA when performing precise base substitution on plant cells without additionally introducing donor DNA.
  • mouse cytosine deaminase APOBEC1 was synthesized in vitro and ligated to the N-terminus of the mutated Cas9 (D10A), and the fusion protein was formed by 16aa XTEN flexible short peptide, and its nucleotide sequence is SEQ ID NO.:1. Shown as follows:
  • This sequence was constructed into the rice pCambia1300 vector (purchased from the Camiba Institute, Australia) and initiated by the plant strong promoter UBI. At the same time, the expression cassette of the guide RNA was also constructed into the vector to generate the vector pCSGAPO1 (Fig. 2A). This vector was applied to the following examples.
  • NRT1.1B can control the absorption of nutrient nitrogen in rice and increase yield
  • SLR1 controls the synthesis of gibberellin and affects the height of rice plants.
  • the amino acid to be edited in rice NRT1.1B gene is Thr327, and the amino acid to be edited in SLR1 gene is Ser97.
  • the targets separately.
  • the cytosine C to be replaced is all within the "deamination window" of the target. Therefore, we constructed the guide RNA expression cassettes (SEQ ID NO.: 2 and SEQ ID NO.: 3) of these two targets to the vector pCSGAPO1 (obtained from Shanghai Institute of Biological Sciences, Chinese Academy of Sciences) to obtain base substitution.
  • the above two vectors were transformed into Agrobacterium EAH105, and then the callus of Flower 11 in rice was transformed. After 4 weeks of screening culture, 100-200 resistant calli granules were selected and added to the new medium for 2 weeks. Finally, all the resistant callus granules were picked out, and the genomic DNA was extracted and mixed for base substitution detection.
  • the two base substitution vectors pCSGAPO1-NRT and pCSGAPO1-SLR1 in Example 1 were transformed into Agrobacterium EHA105, and 37 transgenic plants editing NRT1.1B and 45 transgenes editing SLR1 were obtained by conventional rice genetic transformation. Plant (Table 2).
  • the base substitution of the site can be detected by restriction enzyme polymorphism.
  • StyI can digest it into two bands of 90 bp + 314 bp.
  • the results showed that 6 of the 45 transgenic plants editing SLR1 produced C ⁇ T base substitution at position 6 of their guide RNA.
  • the Sanger sequencing analysis of these 45 plants further verified the experimental results.
  • the animal promoter cannot perform site-based base substitution on the plant of the present invention (such as rice), and only the plant promoter of the present invention (especially a rice-specific strong promoter) can be used for the plant of the present invention (for example, rice) performs site-based base substitution, and the base substitution efficiency is up to 11.5%, and up to 60% of cells in a mutant plant have base substitutions.
  • TALE transcription activator-like effector

Abstract

Disclosed are a nucleic acid construct having a particular structure, and a method for a base mutation or a base substitution on a particular site of a plant genome using the construct. The nucleic acid construct comprises a first expression cassette, a second expression cassette and an optional third expression cassette, wherein the first expression cassette is an expression cassette for expressing gRNAs, the second expression cassette is an expression cassette for expressing a fusion protein comprising a CAS9 and cytosine deaminase, and the third expression cassette is an expression cassette for expressing a selection marker.

Description

一种用于植物基因组定点碱基替换的载体Vector for site-based base substitution of plant genome 技术领域Technical field
本发明涉及生物技术领域,具体地,涉及一种用于植物基因组定点碱基替换的载体以及植物基因组定点碱基替换的方法。The present invention relates to the field of biotechnology, and in particular to a vector for site-based base substitution of a plant genome and a method for site-based base substitution of a plant genome.
背景技术Background technique
锌指核酸技术(Zinc finger nuclease,ZFN)、转录激活因子样效应物核酸酶技术(transcription activator-like(TAL)effector nucleases,Talen)和CRISPR/Cas9技术是这几年基因组编辑领域的几项突破性技术1-3。这三种技术都可以在生物体基因组指定位点特异性的切割DNA产生双链断裂,从而利用生物的非同源末端连接或同源重组,进行定点编辑。ZFN和Talen技术用特异性的蛋白引导,蛋白元件的构建相对较复杂,编辑效率有待提高。CRISPR/Cas9技术以RNA引导,体外构建简单,编辑效率较高。目前,这三种技术已成功的应用于多种生物,包括大肠杆菌、酵母、水稻、拟南芥、大豆、玉米、小鼠和人类细胞等4Zinc finger nuclease (ZFN), transcription activator-like (TAL) effector nucleases (Talen) and CRISPR/Cas9 technologies are several breakthroughs in the field of genome editing in recent years. Sexual techniques 1-3 . All three techniques can generate double-strand breaks in a specific site-specific cleavage DNA in an organism's genome, thereby performing site-directed editing using non-homologous end joining or homologous recombination of the organism. The ZFN and Talen technologies are guided by specific proteins, the construction of protein components is relatively complicated, and the editing efficiency needs to be improved. The CRISPR/Cas9 technology is guided by RNA, which is simple to construct in vitro and has high editing efficiency. Currently, three techniques have been successfully applied to a variety of organisms, including E. coli, yeast, rice, Arabidopsis, soybean, corn, and other four mice and human cells.
基因组编辑技术在生物体基因组的指定位点引入双链断裂后,其编辑的结果都是随机的碱基插入或缺失(Indel)4。到目前为止,在植物基因组中进行精确的碱基替换一直是一项难题,其实现途径主要是同源重组,即通过外源供体DNA来实现碱基替换,但是其效率非常低,至今还尚未有效应用于植物研究和育种。现有的几个发表在国际顶级期刊的碱基替换的报道都还只是瞬时表达实验5,6,或者其编辑位点本身就是筛选标签7,例如除草剂双草醚的靶基因乙酸乳酸合成酶ALS等8。另一方面,大规模的基因测序表明,重要的农艺性状位点大多都是单碱基改变9,10。因此,在植物研究和育种领域,迫切需要一种能够进行高效的碱基替换的方法。After the genome editing technique introduces a double-strand break at a given site in the genome of an organism, the result of editing is a random base insertion or deletion (Indel) 4 . So far, accurate base substitution in plant genomes has been a difficult problem. The main way to achieve this is homologous recombination, which is to achieve base substitution by exogenous donor DNA, but its efficiency is very low. Not yet effectively applied to plant research and breeding. Several existing reports on base substitutions in top international journals are only transient expression experiments 5,6 , or the editing site itself is the screening tag 7 , such as the target gene of the herbicide bispyribyl acetate, lactate synthase. ALS, etc. 8 . On the other hand, large-scale gene sequencing indicates that most of the important agronomic trait loci are single base changes 9,10 . Therefore, in the field of plant research and breeding, there is an urgent need for a method capable of efficient base substitution.
因此,本领域迫切需要在植物领域建立一套适用于植物细胞的高效的定点碱基替换工具,并且可获得稳定植株,从而有效的应用于植物研究和育种。Therefore, there is an urgent need in the art to establish a set of efficient site-selective base replacement tools suitable for plant cells in the field of plants, and to obtain stable plants, thereby being effectively applied to plant research and breeding.
发明内容Summary of the invention
本发明的目的在于提供一种适用于植物细胞的高效的定点碱基替换工具, 并且可获得稳定植株,从而有效的应用于植物研究和育种。The object of the present invention is to provide an efficient fixed-point base replacement tool suitable for plant cells. And stable plants can be obtained, which can be effectively applied to plant research and breeding.
本发明第一方面提供了一种用于对植物进行基因编辑的核酸构建物,所述的核酸构建物包括:A first aspect of the invention provides a nucleic acid construct for genetically editing a plant, the nucleic acid construct comprising:
第一表达盒;First expression cassette;
第二表达盒;和a second expression cassette; and
任选的第三表达盒;An optional third expression cassette;
其中,所述第一表达盒为用于表达gRNA的gRNA表达盒;Wherein the first expression cassette is a gRNA expression cassette for expressing gRNA;
所述第二表达盒为用于表达融合蛋白的融合蛋白表达盒,所述的融合蛋白具有式Ia或Ib结构:The second expression cassette is a fusion protein expression cassette for expression of a fusion protein having the structure of Formula Ia or Ib:
A-L1-B-L2-C    (Ia)A-L1-B-L2-C (Ia)
B-L1-A-L2-C    (Ia)B-L1-A-L2-C (Ia)
各式中,In various styles,
A为胞嘧啶脱氨基酶;A is a cytosine deaminase;
L1为无或第一连接肽(如Xten)L1 is no or the first linker peptide (such as Xten)
B为无切割活性的Cas9或仅具有单链切割活性的Cas9;B is Cas9 without cleavage activity or Cas9 having only single-strand cleavage activity;
L2为无或第二连接肽(如Xten);L2 is a no or second linker peptide (such as Xten);
C为无或Uracil DNA glycosylase inhibitor(UGI);C is no or Uracil DNA glycosylase inhibitor (UGI);
所述第三表达盒为用于表达筛选标记的筛选标记表达盒;The third expression cassette is a selection marker expression cassette for expressing a selection marker;
并且,所述的第一表达盒、第二表达盒、和第三表达盒各自独立地位于相同或不同的载体上。And, the first expression cassette, the second expression cassette, and the third expression cassette are each independently located on the same or different carriers.
在另一优选例中,所述的第一表达盒具有式A结构:In another preferred embodiment, the first expression cassette has the structure of formula A:
X1-X2-X3   (A)X1-X2-X3 (A)
式中,In the formula,
X1为植物启动子,优选植物聚合酶III驱动的启动子(如U6、U3启动子);X1 is a plant promoter, preferably a plant polymerase III driven promoter (such as U6, U3 promoter);
X2为gRNA的编码序列;X2 is the coding sequence of gRNA;
X3为polyT。X3 is polyT.
在另一优选例中,所述的第二表达盒具有式B结构:In another preferred embodiment, the second expression cassette has the structure of formula B:
Y1-Y2-Y3   (B)Y1-Y2-Y3 (B)
式中, In the formula,
Y1为植物启动子,优选UBI、CaMV35S、Actin启动子;Y1 is a plant promoter, preferably UBI, CaMV35S, Actin promoter;
Y2为融合蛋白的编码序列,所述融合蛋白具有如上所述的式Ia或Ib结构;Y2 is the coding sequence of a fusion protein having the structure of formula Ia or Ib as described above;
Y3为终止子。Y3 is a terminator.
在另一优选例中,所述的第三表达盒具有式C结构:In another preferred embodiment, the third expression cassette has the structure of formula C:
Z1-Z2-Z3   (C)Z1-Z2-Z3 (C)
式中,In the formula,
Z1为植物启动子,优选35S、UBI、Actin启动子;Z1 is a plant promoter, preferably a 35S, UBI, Actin promoter;
Z2为编码筛选标记的编码序列;Z2 is a coding sequence encoding a screening marker;
Z3为终止子。Z3 is the terminator.
在另一优选例中,所述的筛选标记选自下组:潮霉素的抗性基因(HYG)、G418和卡那霉素的抗性基因(NPTII)、Basta的抗性基因(BAR)、嘌呤霉素抗性基因(PAC)、新霉素抗性基因(NEO)、或其组合。In another preferred embodiment, the selection marker is selected from the group consisting of a hygromycin resistance gene (HYG), a G418 and kanamycin resistance gene (NPTII), and a Basta resistance gene (BAR). , puromycin resistance gene (PAC), neomycin resistance gene (NEO), or a combination thereof.
在另一优选例中,所述的第一表达盒和第二表达盒位于同一的载体上。In another preferred embodiment, the first expression cassette and the second expression cassette are located on the same carrier.
在另一优选例中,所述的第一表达盒、第二表达盒和第三表达盒位于同一的载体上。In another preferred embodiment, the first expression cassette, the second expression cassette, and the third expression cassette are located on the same carrier.
在另一优选例中,所述的第二表达盒和第三表达盒位于同一的载体上。In another preferred embodiment, the second expression cassette and the third expression cassette are located on the same carrier.
在另一优选例中,所述的载体为可转染或转化植物细胞的表达载体。In another preferred embodiment, the vector is an expression vector that can be transfected or transformed into a plant cell.
在另一优选例中,所述的载体为农杆菌Ti载体。In another preferred embodiment, the carrier is an Agrobacterium Ti carrier.
在另一优选例中,当第一表达盒、第二表达盒和第三表达盒中的两个或三个位于同一载体时,所述的二个或三个表达盒是成簇排列的,从而构成表达盒簇(cluster)。In another preferred embodiment, when two or three of the first expression cassette, the second expression cassette, and the third expression cassette are located on the same vector, the two or three expression cassettes are arranged in clusters. Thereby an expression cassette is constructed.
在另一优选例中,在所述表达盒簇的5’端外侧含有RB序列;并且在所述表达盒簇的3’端外侧含有LB序列。In another preferred embodiment, the RB sequence is contained outside the 5' end of the expression cassette, and the LB sequence is contained outside the 3' end of the expression cassette.
在另一优选例中,所述的表达盒簇中,各表达盒的排列次序(从5’-3’)选自下组:In another preferred embodiment, in the expression cassette, the order of arrangement of each expression cassette (from 5'-3') is selected from the group consisting of:
第一表达盒和第二表达盒;a first expression cassette and a second expression cassette;
第一表达盒、第二表达盒和第三表达盒;a first expression cassette, a second expression cassette, and a third expression cassette;
第二表达盒、第一表达盒和第三表达盒;a second expression cassette, a first expression cassette, and a third expression cassette;
第三表达盒、第二表达盒和第一表达盒;a third expression cassette, a second expression cassette, and a first expression cassette;
第三表达盒、第一表达盒和第二表达盒; a third expression cassette, a first expression cassette, and a second expression cassette;
第三表达盒、第二表达盒;a third expression cassette, a second expression cassette;
第二表达盒、第三表达盒。a second expression cassette, a third expression cassette.
在另一优选例中,所述的第一表达盒和第二表达盒位于不同的载体上。In another preferred embodiment, the first expression cassette and the second expression cassette are located on different vectors.
在另一优选例中,当单个表达盒位于一载体时,则在所述表达盒的5’端外侧含有RB序列;并且在所述表达盒的3’端外侧含有LB序列。In another preferred embodiment, when a single expression cassette is located on a vector, the RB sequence is contained outside the 5' end of the expression cassette; and the LB sequence is contained outside the 3' end of the expression cassette.
本发明第二方面提供了一种表达载体,所述表达载体含有如本发明第一方面所述的核酸构建物,其中,所述的第一表达盒、第二表达盒、和第三表达盒各自独立地位于相同或不同的载体上。A second aspect of the invention provides an expression vector comprising the nucleic acid construct of the first aspect of the invention, wherein the first expression cassette, the second expression cassette, and the third expression cassette They are each independently located on the same or different carriers.
在另一优选例中,所述的表达载体骨架为pCamiba1300。In another preferred embodiment, the expression vector backbone is pCamiba1300.
在另一优选例中,所述的载体为可转染或转化植物细胞的表达载体。In another preferred embodiment, the vector is an expression vector that can be transfected or transformed into a plant cell.
在另一优选例中,所述的载体为农杆菌Ti载体。In another preferred embodiment, the carrier is an Agrobacterium Ti carrier.
在另一优选例中,所述载体是环状的或者是线性的。In another preferred embodiment, the carrier is cyclic or linear.
本发明第三方面提供了一种宿主细胞,所述细胞含有本发明第二方面所述的表达载体。A third aspect of the invention provides a host cell comprising the expression vector of the second aspect of the invention.
在另一优选例中,所述的宿主细胞为农杆菌。In another preferred embodiment, the host cell is Agrobacterium.
在另一优选例中,所述的宿主细胞为植物细胞。In another preferred embodiment, the host cell is a plant cell.
本发明第四方面提供了一种基因工程细胞,所述的细胞含有本发明第一方面所述的构建物,或其基因组整合有一个或多个本发明第一方面所述的构建物。A fourth aspect of the invention provides a genetically engineered cell comprising the construct of the first aspect of the invention, or a genome thereof integrated with one or more of the constructs of the first aspect of the invention.
在另一优选例中,所述的细胞为植物细胞。In another preferred embodiment, the cell is a plant cell.
在另一优选例中,所述的植物选自下组:禾本科植物、豆科植物、十字花科植物、或其组合。In another preferred embodiment, the plant is selected from the group consisting of a gramineous plant, a leguminous plant, a cruciferous plant, or a combination thereof.
在另一优选例中,所述的植物选自下组:水稻、大豆、番茄、玉米、烟草、小麦、高粱、拟南芥、大麦、燕麦、粟、花生、或其组合。In another preferred embodiment, the plant is selected from the group consisting of rice, soybean, tomato, corn, tobacco, wheat, sorghum, Arabidopsis thaliana, barley, oats, millet, peanuts, or combinations thereof.
在另一优选例中,所述的基因工程细胞是用选自下组的方法将本发明第一方面所述的构建物导入细胞的:农杆菌转化法、基因枪法、显微注射法、电击法、超声波法、聚乙二醇(PEG)介导法、或其组合。In another preferred embodiment, the genetically engineered cell is introduced into the cell by the method according to the first aspect of the invention by a method selected from the group consisting of Agrobacterium transformation, gene gun, microinjection, and electric shock. Method, ultrasonic method, polyethylene glycol (PEG) mediated method, or a combination thereof.
本发明第五方面提供了一种对植物进行基因编辑的方法,包括步骤:A fifth aspect of the invention provides a method for genetically editing a plant, comprising the steps of:
(i)提供待编辑植物;(i) providing the plant to be edited;
(ii)将本发明第二方面所述的表达载体导入所述待编辑植物。(ii) introducing the expression vector of the second aspect of the invention into the plant to be edited.
在另一优选例中,所述导入为通过农杆菌导入。In another preferred embodiment, the introduction is introduced by Agrobacterium.
在另一优选例中,所述导入为通过基因枪导入。 In another preferred embodiment, the introduction is by a gene gun.
在另一优选例中,所述的基因编辑为定点碱基替换。In another preferred embodiment, the gene is edited as a fixed-point base substitution.
在另一优选例中,所述的定点突变包括将C突变为T或者C突变为GIn another preferred embodiment, the site-directed mutagenesis comprises mutating C to T or C to G
在另一优选例中,所述的定点突变包括将PAM远端第4-8位中的C进行定点突变。In another preferred embodiment, the site-directed mutagenesis comprises site-directed mutagenesis of C in positions 4-8 of the distal end of the PAM.
本发明第六方面提供了一种制备转基因植物细胞的方法,包括步骤:A sixth aspect of the invention provides a method of preparing a transgenic plant cell, comprising the steps of:
(i)将本发明第一方面所述的构建物、或本发明第二方面所述的载体转染植物细胞,使得所述构建物与所述植物细胞中的染色体发生定点突变,从而制得所述转基因植物细胞。(i) transfecting the construct of the first aspect of the invention, or the vector of the second aspect of the invention, with a plant cell such that the construct is site-directed with the chromosome in the plant cell, thereby producing The transgenic plant cell.
在另一优选例中,所述的转染采用农杆菌转化法或基因枪轰击法。In another preferred embodiment, the transfection is performed using an Agrobacterium transformation method or a gene gun bombardment method.
本发明第七方面提供了一种制备转基因植物细胞的方法,包括步骤:A seventh aspect of the invention provides a method of preparing a transgenic plant cell, comprising the steps of:
(i)将本发明第一方面所述的构建物、或本发明第二方面所述的载体转染植物细胞,使得所述植物细胞含有所述构建物,从而制得所述转基因植物细胞。(i) transfecting the construct of the first aspect of the invention, or the vector of the second aspect of the invention, with a plant cell such that the plant cell contains the construct, thereby producing the transgenic plant cell.
本发明第八方面提供了一种制备转基因植物的方法,包括步骤:An eighth aspect of the invention provides a method of preparing a transgenic plant, comprising the steps of:
将本发明第六方面或本发明第七方面所述方法制备的所述转基因植物细胞再生为植物体,从而获得所述转基因植物。The transgenic plant cell prepared by the method of the sixth aspect of the invention or the method of the seventh aspect of the invention is regenerated into a plant body, thereby obtaining the transgenic plant.
本发明第九方面提供了一种转基因植物,所述的植物是用本发明第八方面所述的方法制备的,或者所述植物的植物细胞中含有本发明第一方面所述的构建物或其基因组整合有一个或多个本发明第一方面所述的构建物。A ninth aspect of the invention provides a transgenic plant, which is prepared by the method of the eighth aspect of the invention, or the plant cell of the plant comprises the construct of the first aspect of the invention or The genome is integrated with one or more of the constructs of the first aspect of the invention.
应理解,在本发明范围内中,本发明的上述各技术特征和在下文(如实施例)中具体描述的各技术特征之间都可以互相组合,从而构成新的或优选的技术方案。限于篇幅,在此不再一一累述。It is to be understood that within the scope of the present invention, the various technical features of the present invention and the various technical features specifically described hereinafter (as in the embodiments) may be combined with each other to constitute a new or preferred technical solution. Due to space limitations, we will not repeat them here.
附图说明DRAWINGS
图1基于胞嘧啶脱氨酶的定点碱基替换示意图。将表达Cas的DNA序列与表达胞嘧啶脱氨基酶的DNA序列连接,转化植物受体,使转化的植物细胞中的DNA表达该融合蛋白和guide RNA。融合胞嘧啶脱氨基酶(103)的Cas蛋白(101)在其guide RNA(102)的引导下,将植物基因组(104)中靶点位置的胞嘧啶C脱氨基生成尿嘧啶U,然后在植物细胞的修复系统作用下,将U修复成T或G。Figure 1 is a schematic diagram of site-based base substitution based on cytosine deaminase. The DNA sequence expressing Cas is ligated to a DNA sequence expressing cytosine deaminase, transformed into a plant receptor, and the DNA in the transformed plant cell expresses the fusion protein and guide RNA. The Cas protein (101) fused with cytosine deaminase (103), under the guidance of its guide RNA (102), deamination of cytosine C at the target position in the plant genome (104) to uracil U, then in plants Repair the U to T or G by the cell's repair system.
图2采用APOBEC1和CRISPR/Cas9的定点碱基替换载体。(A)载体pCSGAPO1的示意图。(B)脱氨基区域示意图。 Figure 2 uses a fixed-base replacement vector of APOBEC1 and CRISPR/Cas9. (A) Schematic representation of the vector pCSGAPO1. (B) Schematic diagram of the deamination region.
图3水稻愈伤组织定点碱基替换结果。(A)水稻NRT1.1B基因碱基替换示意图。(B)水稻SLR1基因碱基替换示意图。(C)高通量测序检测结果。Figure 3. Results of fixed-base substitution of rice callus. (A) Schematic diagram of base substitution of rice NRT1.1B gene. (B) Schematic diagram of base substitution of rice SLR1 gene. (C) High-throughput sequencing results.
图4水稻转基因植株中NRT1.1B基因的碱基替换结果。(A)Indel植株(#35)和碱基替换植株(#15)的Sanger测序结果。(B)碱基替换植株(#15)的PCR产物单菌落测序结果。Figure 4. Base substitution results of the NRT1.1B gene in rice transgenic plants. (A) Sanger sequencing results of Indel plants (#35) and base replacement plants (#15). (B) Single colony sequencing results of PCR products of base replacement plants (#15).
图5水稻转基因植株中SLR1基因的碱基替换结果。(A)StyI酶切检测示意图及结果。(B)Indel植株(#07)和碱基替换植株(#07、#10、#18、#23、#28和#37)的Sanger测序结果。(C)碱基替换植株(#07)的单菌落测序结果。(D)SLR1基因野生型(WT)、敲除(SLR#09)和碱基替换(SLR#07)的T0代植株表型。Figure 5 shows the results of base substitution of the SLR1 gene in rice transgenic plants. (A) Schematic and results of StyI digestion assay. (B) Sanger sequencing results of Indel plants (#07) and base substitution plants (#07, #10, #18, #23, #28, and #37). (C) Single colony sequencing results of base replacement plants (#07). (D) T0 generation plant phenotype of wild type (WT), knockout (SLR#09) and base substitution (SLR#07) of SLR1 gene.
具体实施方式detailed description
本发明人经过广泛而深入地研究,通过大量筛选,筛选出针对特异性位点的优化的启动子,通过采用特定结构的核酸构建物,本发明首次在植物中成功实现了RNA引导的碱基定点突变(如C突变为T或G),并且突变效率可高达11.5%,并且在一个突变植株内,有高达60%的细胞发生了替换。The present inventors have extensively and intensively studied to screen out optimized promoters for specific sites by extensive screening, and by using a nucleic acid construct of a specific structure, the present invention successfully achieves RNA-directed bases in plants for the first time. Site-directed mutagenesis (such as C mutation to T or G), and mutation efficiency can be as high as 11.5%, and up to 60% of cells in a mutant plant have been replaced.
具体地,本发明首次发现胞嘧啶脱氨基酶能够在CRISPR/Cas9的引导下,在植物细胞的基因组上定点修改靶点上的胞嘧啶,将其突变为T或G,并在此基础上完成了本发明。Specifically, the present invention finds for the first time that cytosine deaminase can cleave the cytosine on the target genome of a plant cell under the guidance of CRISPR/Cas9, mutate it to T or G, and complete on this basis. The invention has been made.
如本文所用,术语“碱基替换”、碱基突变”可互换使用,均指将某一碱基突变为其他碱基,比如C突变为T或者C突变为G。As used herein, the terms "base substitution", base mutation, are used interchangeably and refer to the mutation of a base to another base, such as a C mutation to T or a C mutation to G.
如本文所用,“筛选标记基因”指转基因过程中用来筛选转基因细胞或转基因动物的基因,可用于本申请的筛选标记基因没有特别限制,包括转基因领域常用的各种筛选标记基因,代表性例子包括(但并不限于):潮霉素抗性基因(Hyg)、卡那霉素抗性基因(NPTII)、新霉素基因、嘌呤霉素抗性基因、潮霉素的抗性基因(HYG)、G418和卡那霉素的抗性基因(NPTII)、Basta的抗性基因(BAR)、嘌呤霉素抗性基因(PAC)、和/或新霉素抗性基因(NEO)。As used herein, "screening marker gene" refers to a gene used for screening a transgenic cell or a transgenic animal in a transgenic process, and the screening marker gene useful in the present application is not particularly limited, and includes various screening marker genes commonly used in the transgenic field, representative examples. Including (but not limited to): hygromycin resistance gene (Hyg), kanamycin resistance gene (NPTII), neomycin gene, puromycin resistance gene, hygromycin resistance gene (HYG , G418 and kanamycin resistance gene (NPTII), Basta resistance gene (BAR), puromycin resistance gene (PAC), and/or neomycin resistance gene (NEO).
如本文所用,术语“表达盒”是指含有待表达基因以及表达所需元件的序列组件的一段多聚核苷酸序列。例如,在本发明中,术语“筛选标记表达盒”指含有编码筛选标记的序列以及表达所需元件的序列组件的多聚核苷酸序列。 表达所需的组件包括启动子和聚腺苷酸化信号序列。此外,筛选标记表达盒还可以含有或不含有其他序列,包括(但并不限于):增强子、分泌信号肽序列等。As used herein, the term "expression cassette" refers to a stretch of polynucleotide sequences comprising a gene to be expressed and a sequence component that expresses the desired element. For example, in the present invention, the term "screening marker expression cassette" refers to a polynucleotide sequence comprising a sequence encoding a selection marker and a sequence component expressing the desired element. The components required for expression include a promoter and a polyadenylation signal sequence. In addition, the selection marker expression cassette may or may not contain other sequences including, but not limited to, enhancers, secretion signal peptide sequences, and the like.
在本发明中,适用于外源基因表达盒和筛选标记基因表达盒的启动子可以是任何一种常见的启动子,它可以是组成型启动子或诱导型启动子。较佳地,该启动子是组成型启动子,例如UBI启动子等其它适用于真核表达的植物启动子。In the present invention, the promoter suitable for the exogenous gene expression cassette and the selection marker gene expression cassette may be any of the common promoters, and it may be a constitutive promoter or an inducible promoter. Preferably, the promoter is a constitutive promoter, such as a UBI promoter, and other plant promoters suitable for eukaryotic expression.
如本文所用,术语“植物启动子”指能够在植物细胞中启动核酸转录的核酸序列。该植物启动子可以是来源于植物、微生物(如细菌、病毒)或动物等,或者是人工合成或改造过的启动子。The term "plant promoter" as used herein refers to a nucleic acid sequence capable of initiating transcription of a nucleic acid in a plant cell. The plant promoter may be derived from a plant, a microorganism (such as a bacterium, a virus) or an animal, or a synthetic or engineered promoter.
如本文所用,术语“植物终止子”指能够在植物细胞中可使转录停止的终止子。该植物转录终止子可以是来源于植物、微生物(如细菌、病毒)或动物等,或者是人工合成或改造过的终止子。代表性的例子包括(但并不限于):Nos终止子。As used herein, the term "plant terminator" refers to a terminator capable of stopping transcription in a plant cell. The plant transcription terminator may be derived from a plant, a microorganism (such as a bacterium, a virus) or an animal, or a synthetic or engineered terminator. Representative examples include (but are not limited to): Nos terminator.
如本文所用,术语“Cas蛋白”指一种核酸酶。一种优选的Cas蛋白是Cas9蛋白。典型的Cas9蛋白包括(但并不限于):来源于酿脓链球菌(Streptococcuspyogenes)的Cas9。在本发明中,Cas9蛋白为突变的Cas9蛋白,具体地,是无切割活性或只具有单链切割活性的突变的Cas9蛋白。The term "Cas protein" as used herein refers to a nuclease. A preferred Cas protein is the Cas9 protein. Typical Cas9 proteins include, but are not limited to, Cas9 derived from Streptococcus pyogenes. In the present invention, the Cas9 protein is a mutated Cas9 protein, specifically, a mutant Cas9 protein having no cleavage activity or only single-strand cleavage activity.
如本文所用,术语“Cas蛋白的编码序列”指编码Cas蛋白的核苷酸序列。在插入的多聚核苷酸序列被转录和翻译从而产生功能性Cas蛋白的情况下,技术人员会认识到,因为密码子的简并性,有大量多聚核苷酸序列可以编码相同的多肽。另外,技术人员也会认识到不同物种对于密码子具有一定的偏好性,可能会根据在不同物种中表达的需要,会对Cas蛋白的密码子进行优化,这些变异体都被术语“Cas蛋白的编码序列”所具体涵盖。此外,术语特定地包括了全长的、与Cas基因序列基本相同的序列,以及编码出保留Cas蛋白功能的蛋白质的序列。As used herein, the term "coding sequence of a Cas protein" refers to a nucleotide sequence that encodes a Cas protein. In the case where the inserted polynucleotide sequence is transcribed and translated to produce a functional Cas protein, the skilled artisan will recognize that because of the degeneracy of the codon, a large number of polynucleotide sequences can encode the same polypeptide. . In addition, the skilled person will also recognize that different species have a certain preference for codons, and may optimize the codons of the Cas protein according to the needs of expression in different species. These variants are all referred to by the term "Cas protein. The coding sequence is specifically covered. Furthermore, the term specifically encompasses a full-length sequence substantially identical to the Cas gene sequence, as well as a sequence encoding a protein that retains the function of the Cas protein.
如本文所用,术语“植物”包括全植株、植物器官(如叶、茎、根等)、种子和植物细胞以及它们的子代。可用于本发明方法的植物的种类没有特别限制,一般包括任何可进行转化技术的高等植物类型,包括单子叶、双子叶植物和裸子植物。As used herein, the term "plant" includes whole plants, plant organs (such as leaves, stems, roots, etc.), seeds and plant cells, and progeny thereof. The kind of plant which can be used in the method of the present invention is not particularly limited, and generally includes any higher plant type which can be subjected to transformation techniques, including monocots, dicots, and gymnosperms.
本发明的构建物 Construct of the invention
在本发明中,提供了一种核酸构建物,用于对植物进行基因编辑,所述的核酸构建物包括:In the present invention, a nucleic acid construct for gene editing of a plant is provided, the nucleic acid construct comprising:
第一表达盒;First expression cassette;
第二表达盒;和a second expression cassette; and
任选的第三表达盒;An optional third expression cassette;
其中,第一表达盒为用于表达gRNA的gRNA表达盒;Wherein the first expression cassette is a gRNA expression cassette for expressing gRNA;
第二表达盒为用于表达融合蛋白的融合蛋白表达盒,所述的融合蛋白具有式Ia或Ib结构:The second expression cassette is a fusion protein expression cassette for expression of a fusion protein having the structure of Formula Ia or Ib:
A-L1-B-L2-C   (Ia)A-L1-B-L2-C (Ia)
B-L1-A-L2-C   (Ia)B-L1-A-L2-C (Ia)
各式中,In various styles,
A为胞嘧啶脱氨基酶;A is a cytosine deaminase;
L1为无或第一连接肽(如Xten)L1 is no or the first linker peptide (such as Xten)
B为无切割活性的Cas9或仅具有单链切割活性的Cas9;B is Cas9 without cleavage activity or Cas9 having only single-strand cleavage activity;
L2为无或第二连接肽(如Xten);L2 is a no or second linker peptide (such as Xten);
C为无或Uracil DNA glycosylase inhibitor(UGI);C is no or Uracil DNA glycosylase inhibitor (UGI);
第三表达盒为用于表达筛选标记的筛选标记表达盒;The third expression cassette is a selection marker expression cassette for expressing a selection marker;
并且,所述的第一表达盒、第二表达盒、和第三表达盒各自独立地位于相同或不同的载体上。And, the first expression cassette, the second expression cassette, and the third expression cassette are each independently located on the same or different carriers.
本发明的构建物中所用的各种元件都是本领域中已知的,因此本领域技术人员可以用常规方法,如PCR方法、全人工化学合成法、酶切方法获得相应的元件,然后通过熟知的DNA连接技术连接在一起,就形成了本发明的构建物。The various elements used in the constructs of the present invention are known in the art, and thus those skilled in the art can obtain corresponding elements by conventional methods such as PCR methods, full artificial chemical synthesis, and enzymatic cleavage methods, and then pass The well-known DNA ligation techniques are joined together to form the constructs of the present invention.
将本发明的构建物插入外源载体(尤其是适合转基因植物操作的载体),就构成了本发明的载体。The construction of the present invention is carried out by inserting the construct of the present invention into an exogenous vector, especially a vector suitable for transgenic plant manipulation.
将本发明的载体转化植物细胞从而介导本发明的载体对植物细胞染色体进行整合,制得转基因植物细胞。The transgenic plant cells are prepared by transforming the vector of the present invention into plant cells to mediate the integration of the plant cell chromosomes by the vector of the present invention.
将本发明的转基因植物细胞再生为植物体,从而获得转基因植物。The transgenic plant cells of the present invention are regenerated into plant bodies to obtain transgenic plants.
将本发明构建好的上述核酸构建物,通过常规的植物重组技术(例如农杆菌转让技术),可以导入植物细胞,从而获得携带所述核酸构建物(或带有所述核酸构建物的载体)的植物细胞,或获得基因组中整合有所述核酸构建物的植物细胞。 The above nucleic acid construct constructed by the present invention can be introduced into a plant cell by a conventional plant recombination technique (for example, Agrobacterium transfer technology) to obtain a nucleic acid construct (or a vector carrying the nucleic acid construct). Plant cells, or plant cells in the genome in which the nucleic acid construct is integrated.
载体构建Vector construction
该载体的主要特征是将胞嘧啶脱氨基酶与CRISPR/Cas系统中的Cas蛋白连接形成融合蛋白,并由guide RNA引导至基因组中的靶点位置。由于胞嘧啶脱氨基酶直接将胞嘧啶C脱氨基生成U,并不需要Cas蛋白的DNA双链切割活性。因此,在本发明中Cas蛋白是无切割活性的突变的Cas蛋白。胞嘧啶C脱氨基生成U后,植物细胞启动碱基错配修复,将U-G修复为T-A或者C-G。为了增加U-G转化为T-A的比例,可以保留Cas蛋白的DNA单链切刻活性,即在非编辑单链(编辑靶点C的匹配链)造成单链切刻。因此,优选的,将胞嘧啶脱氨基酶与具有单链切刻活性的Cas蛋白融合,形成融合蛋白。一般的,为了增加融合蛋白的活性,蛋白间一般通过一些柔性短肽连接,即Linker。优选的,该Linker可以选用XTEN。The main feature of this vector is the linkage of cytosine deaminase to the Cas protein in the CRISPR/Cas system to form a fusion protein, which is directed by the guide RNA to a target site in the genome. Since cytosine deaminase directly deacetylates cytosine C to form U, DNA double-strand cleavage activity of Cas protein is not required. Therefore, in the present invention, the Cas protein is a mutant Cas protein having no cleavage activity. After deamination of cytosine C to form U, plant cells initiate base mismatch repair and repair U-G to T-A or C-G. In order to increase the ratio of U-G to T-A, the DNA single-strand nicking activity of the Cas protein can be retained, that is, the single-strand nicking is caused in the non-edited single strand (editing the matching strand of the target C). Therefore, preferably, the cytosine deaminase is fused to a Cas protein having single-strand nicking activity to form a fusion protein. In general, in order to increase the activity of the fusion protein, the proteins are usually linked by some flexible short peptides, namely Linker. Preferably, the Linker can use XTEN.
为了增加修复效率,一般选择适用于植物细胞的强启动子,比如CaMV 35S启动子或者UBI启动子等。选择适用于植物细胞的guide RNA的表达框,并将其与上述融合蛋白表达框构建在同一载体。显而易见的,这两个表达框也可以在不同的DNA分子上。In order to increase the efficiency of repair, a strong promoter suitable for plant cells, such as the CaMV 35S promoter or the UBI promoter, is generally selected. The expression cassette of the guide RNA suitable for plant cells is selected and constructed in the same vector as the fusion protein expression cassette described above. Obviously, these two expression cassettes can also be on different DNA molecules.
靶点设计Target design
胞嘧啶脱氨基酶通过CRISPR/Cas9系统引导至靶点位置后,脱氨基酶的作用区域一般固定。例如,将胞嘧啶脱氨基酶APOBEC1蛋白通过16个氨基酸的XTEN Linker连接至Cas9的N端后,其脱氨基的作用区域为guilde RNA的第4-8个碱基区域,该区域即为“脱氨基窗口区”(图2)。根据这一原则,在设计靶点时,需将待编辑的胞嘧啶处于“脱氨基窗口区”。After the cytosine deaminase is directed to the target site by the CRISPR/Cas9 system, the region of action of the deaminase is generally fixed. For example, after the cytosine deaminase APOBEC1 protein is linked to the N-terminus of Cas9 via a 16 amino acid XTEN Linker, the deamination region is the 4-8 base region of the guilde RNA, which is Amino window area" (Figure 2). According to this principle, the cytosine to be edited is in the "deamination window" when designing the target.
遗传转化Genetic transformation
将上述载体通过合适的方法导入到植物受体中。导入方法包括但不局限于:基因枪法、显微注射法、电击法、超声波法和聚乙二醇(PEG)介导法等。受体植物包括但不限于水稻、大豆、番茄、玉米、烟草、小麦、高粱等。上述DNA载体或片段导入植物细胞后,使转化的植物细胞中的DNA表达该融合蛋白和guide RNA。融合胞嘧啶脱氨基酶的Cas蛋白在其guide RNA的引导下,将靶点位置的胞嘧啶C脱氨基生成尿嘧啶U,然后在植物细胞的修复系统作用下,将U修复成T或G。进一步的,通过组织培养获得碱基替换后的植株。 The above vector is introduced into a plant recipient by a suitable method. The introduction methods include, but are not limited to, gene gun method, microinjection method, electric shock method, ultrasonic method, and polyethylene glycol (PEG)-mediated method. Receptor plants include, but are not limited to, rice, soybean, tomato, corn, tobacco, wheat, sorghum, and the like. After the above DNA vector or fragment is introduced into a plant cell, the DNA in the transformed plant cell expresses the fusion protein and the guide RNA. The Cas protein fused with cytosine deaminase, under the guidance of its guide RNA, deamination of cytosine C at the target site to uracil U, and then repairs U to T or G under the action of the plant cell repair system. Further, the plants after base substitution are obtained by tissue culture.
应用application
本发明可以用于植物基因工程领域,用于植物研究和育种,尤其是具有经济价值的农作物和林业作物的遗传改良。The invention can be used in the field of plant genetic engineering for plant research and breeding, especially genetic improvement of economically valuable crops and forestry crops.
本发明的主要优点包括:The main advantages of the invention include:
(1)本发明首次提供了一种在植物中实现定点碱基突变的高效方法,可以广泛的用于植物研究和育种。(1) The present invention provides, for the first time, an efficient method for realizing site-directed base mutations in plants, which can be widely used for plant research and breeding.
(2)本发明的定点碱基突变的方法可高效地在植物细胞的特定位置进行碱基突变(如C突变为T或G)。(2) The method of site-directed base mutation of the present invention can efficiently perform base mutation (e.g., C mutation to T or G) at a specific position of a plant cell.
(3)用本发明的方法在植物细胞中进行碱基突变的效果高达11.5%,并且在一个突变植株内,有高达60%的细胞发生了碱基替换。(3) The effect of base mutation in plant cells by the method of the present invention is as high as 11.5%, and up to 60% of cells in one mutant plant undergo base substitution.
(4)本发明的方法在对植物细胞进行精准碱基替换时,无需额外引入供体DNA,能有效避免外源DNA的随机整合。(4) The method of the present invention can effectively avoid random integration of foreign DNA when performing precise base substitution on plant cells without additionally introducing donor DNA.
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。下列实施例中未注明具体条件的实验方法,通常按照常规条件如Sambrook等人,分子克隆:实验室手册(New York:Cold Spring Harbor Laboratory Press,1989)中所述的条件,或按照制造厂商所建议的条件。除非另外说明,否则百分比和份数按重量计算。本发明中所涉及的实验材料和试剂如无特殊说明均可从市售渠道获得。The invention is further illustrated below in conjunction with specific embodiments. It is to be understood that the examples are not intended to limit the scope of the invention. The experimental methods in the following examples which do not specify the specific conditions are usually carried out according to the conditions described in conventional conditions such as Sambrook et al., Molecular Cloning: Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989), or according to the manufacturer. The suggested conditions. Percentages and parts are by weight unless otherwise stated. The experimental materials and reagents referred to in the present invention can be obtained from commercially available channels unless otherwise specified.
通用方法General method
体外合成小鼠胞嘧啶脱氨基酶APOBEC1,并将其连接至突变的Cas9(D10A)的N端,通过16aa的XTEN柔性短肽连接形成融合蛋白,其核苷酸序列如SEQ ID NO.:1所示:The mouse cytosine deaminase APOBEC1 was synthesized in vitro and ligated to the N-terminus of the mutated Cas9 (D10A), and the fusion protein was formed by 16aa XTEN flexible short peptide, and its nucleotide sequence is SEQ ID NO.:1. Shown as follows:
Figure PCTCN2017077133-appb-000001
Figure PCTCN2017077133-appb-000001
Figure PCTCN2017077133-appb-000002
Figure PCTCN2017077133-appb-000002
Figure PCTCN2017077133-appb-000003
Figure PCTCN2017077133-appb-000003
其蛋白序列如SEQ ID NO.:8所示:Its protein sequence is shown as SEQ ID NO.:
Figure PCTCN2017077133-appb-000004
Figure PCTCN2017077133-appb-000004
将该序列构建至水稻pCambia1300载体(购自澳大利亚Camiba研究所),并由植物强启动子UBI启动表达。同时,将guide RNA的表达框也构建至该载体,生成载体pCSGAPO1(图2A)。将该载体应用于下列实施例。This sequence was constructed into the rice pCambia1300 vector (purchased from the Camiba Institute, Australia) and initiated by the plant strong promoter UBI. At the same time, the expression cassette of the guide RNA was also constructed into the vector to generate the vector pCSGAPO1 (Fig. 2A). This vector was applied to the following examples.
实施例1在水稻愈伤组织中实现定点碱基替换Example 1 Implementation of Site-Based Base Replacement in Rice Callus
首先尝试应用该发明在水稻愈伤中实现碱基替换。我们选择水稻两个重要 的基因NRT1.1B和SLR1。NRT1.1B可以控制水稻营养元素氮的吸收,增加产量;SLR1控制赤霉素的合成,影响水稻植株高度。利用本发明,我们设计相应的靶点,通过高通量测序,成功地在水稻愈伤中检测到定点碱基替换,其效率可达11.5%,远远高于以前的在植物原生质体中的运用同源重组的瞬时实验。具体操作流程如下:First, the application of the invention was attempted to achieve base substitution in rice callus. We choose two important rice The genes NRT1.1B and SLR1. NRT1.1B can control the absorption of nutrient nitrogen in rice and increase yield; SLR1 controls the synthesis of gibberellin and affects the height of rice plants. Using the present invention, we designed corresponding targets and successfully detected fixed-point base substitutions in rice callus by high-throughput sequencing, with an efficiency of 11.5%, which is much higher than in previous plant protoplasts. Transient experiments using homologous recombination. The specific operation process is as follows:
1.1载体构建与遗传转化1.1 Vector Construction and Genetic Transformation
水稻NRT1.1B基因待编辑的氨基酸为Thr327,而SLR1基因待编辑的氨基酸为Ser97。针对这两个位点,我们分别设计了靶点。如图3A和3B所示,待替换的胞嘧啶C都处于靶点的“脱氨基窗口”内。因此,我们分别将这两个靶点的guide RNA表达框(SEQ ID NO.:2和SEQ ID NO.:3)构建至载体pCSGAPO1(获自中国科学院上海生命科学研究院),获得碱基替换载体pCSGAPO1-NRT和pCSGAPO1-SLR1。The amino acid to be edited in rice NRT1.1B gene is Thr327, and the amino acid to be edited in SLR1 gene is Ser97. For these two sites, we designed the targets separately. As shown in Figures 3A and 3B, the cytosine C to be replaced is all within the "deamination window" of the target. Therefore, we constructed the guide RNA expression cassettes (SEQ ID NO.: 2 and SEQ ID NO.: 3) of these two targets to the vector pCSGAPO1 (obtained from Shanghai Institute of Biological Sciences, Chinese Academy of Sciences) to obtain base substitution. Vectors pCSGAPO1-NRT and pCSGAPO1-SLR1.
将上述两个载体转化农杆菌EAH105,然后转化水稻中花11的愈伤组织。经过4周筛选培养后,挑选100-200颗抗性愈伤颗粒至新的培养基上继续筛选2周。最后,挑出全部的抗性愈伤颗粒,混合后提取基因组DNA,进行碱基替换检测。The above two vectors were transformed into Agrobacterium EAH105, and then the callus of Flower 11 in rice was transformed. After 4 weeks of screening culture, 100-200 resistant calli granules were selected and added to the new medium for 2 weeks. Finally, all the resistant callus granules were picked out, and the genomic DNA was extracted and mixed for base substitution detection.
1.2碱基替换效率检测1.2 base substitution efficiency test
在获得总的基因组DNA后,分别设计引物(表1),通过PCR扩增NRT1.1B和SLR1,然后将PCR产物进行高通量测序分析。如图3C所示,在NRT1.1B的靶点位置上,其第7位的胞嘧啶被替换成了T或者G,其效率分别为1.4%和1.6%;在SLR1的靶点位置上,其guide RNA的第4位置产生了C→T碱基替换,其效率为2.9%,而第6位置的胞嘧啶产生了C→T和C→G的碱基替换,其效率分别为11.5%和3.9%。同时,我们也检测到了一定比率的Indel,其由单链切刻活性的Cas9(D10A)导致。由于NRT1.1B所设计的guide RNA的靶向效率低于SLR1,其碱基替换效率也比SLR1低。这些实验结果表明,该发明可有效的应用于植物基因组的定点碱基替换。After obtaining the total genomic DNA, primers were designed (Table 1), NRT1.1B and SLR1 were amplified by PCR, and the PCR products were subjected to high-throughput sequencing analysis. As shown in Fig. 3C, at the target position of NRT1.1B, the cytosine at position 7 was replaced by T or G with an efficiency of 1.4% and 1.6%, respectively; at the target position of SLR1, The 4th position of the guide RNA produced a C→T base substitution with an efficiency of 2.9%, while the cytosine at position 6 produced C→T and C→G base substitutions with efficiencies of 11.5% and 3.9, respectively. %. At the same time, we also detected a certain ratio of Indel, which was caused by single-strand nicking of active Cas9 (D10A). Since the targeting efficiency of guide RNA designed by NRT1.1B is lower than that of SLR1, the base substitution efficiency is also lower than that of SLR1. These experimental results show that the invention can be effectively applied to fixed-point base substitution of plant genomes.
表1.扩增靶点所用的引物Table 1. Primers used to amplify the target
Figure PCTCN2017077133-appb-000005
Figure PCTCN2017077133-appb-000005
Figure PCTCN2017077133-appb-000006
Figure PCTCN2017077133-appb-000006
实施例2获得定点碱基替换的水稻Example 2 Obtaining Rice with Site-Related Base Replacement
将实施例1中的两个碱基替换载体pCSGAPO1-NRT和pCSGAPO1-SLR1转化农杆菌EHA105,通过常规的水稻遗传转化,分别获得了37株编辑NRT1.1B的转基因植株和45株编辑SLR1的转基因植株(表2)。The two base substitution vectors pCSGAPO1-NRT and pCSGAPO1-SLR1 in Example 1 were transformed into Agrobacterium EHA105, and 37 transgenic plants editing NRT1.1B and 45 transgenes editing SLR1 were obtained by conventional rice genetic transformation. Plant (Table 2).
表2.水稻转基因植株的碱基替换效率统计Table 2. Statistics on base substitution efficiency of rice transgenic plants
Figure PCTCN2017077133-appb-000007
Figure PCTCN2017077133-appb-000007
针对37株编辑NRT1.1B的转基因植株,我们采用Sanger测序进行DNA测序分析。测序结果表明,其中4株在靶点位置产生了Indel突变,有1株植株(NRT#15)在其guide RNA的第7位置的胞嘧啶产生了C→G碱基替换。将该转基因植株的PCR扩增产物克隆至T载体,挑选17个单克隆进行测序,结果表明该植株中的C→G碱基替换效率为23.5%(4/17)。For 37 transgenic plants editing NRT1.1B, we used Sanger sequencing for DNA sequencing analysis. Sequencing results showed that 4 of them produced Indel mutations at the target site, and 1 plant (NRT#15) produced C→G base substitution at the 7th position of the guide RNA. The PCR amplification product of the transgenic plant was cloned into the T vector, and 17 monoclonal clones were selected for sequencing. The results showed that the C→G base substitution efficiency in the plant was 23.5% (4/17).
对于SLR1的编辑,由于C→T碱基替换可以产生StyI的酶切位点,因此可以通过酶切多态性检测该位点的碱基替换。如图5A所示,对于C→T碱基替换的PCR产物(404bp),StyI可以将其酶切成90bp+314bp两个条带。实验结果表明,45株编辑SLR1的转基因植株中,有6株在其guide RNA的第6位置产生了C→T的碱基替换。对这45株植株进行Sanger测序分析,进一步验证了该实验结果。我们将转基因植株SLR#07的PCR扩增产物克隆至T载体,挑选10个单克隆进行测序,结果表明该植株中的C→T碱基替换效率为60%(6/10)。该结果与NRT1.1B的编辑结果类似,即SLR1靶点上的胞嘧啶也未被彻底的替换,也就是说转基因植株NRT#15和SLR#07中的碱基替换位点是嵌合的或者杂合的。但是,这些转基因植株中,靶位点上高达23.5%-60%的碱基替换率使其足够遗传至下一代。For the editing of SLR1, since the C→T base substitution can generate the cleavage site of StyI, the base substitution of the site can be detected by restriction enzyme polymorphism. As shown in Figure 5A, for the C→T base-substituted PCR product (404 bp), StyI can digest it into two bands of 90 bp + 314 bp. The results showed that 6 of the 45 transgenic plants editing SLR1 produced C→T base substitution at position 6 of their guide RNA. The Sanger sequencing analysis of these 45 plants further verified the experimental results. We cloned the PCR amplification product of transgenic plant SLR#07 into T vector, and selected 10 monoclonals for sequencing. The results showed that the C→T base substitution efficiency in the plant was 60% (6/10). This result is similar to the editing result of NRT1.1B, that is, the cytosine on the SLR1 target has not been completely replaced, that is, the base substitution sites in the transgenic plants NRT#15 and SLR#07 are chimeric or Heterozygous. However, in these transgenic plants, a base substitution rate of up to 23.5%-60% at the target site is sufficient to inherit to the next generation.
根据以前的研究,SLR1基因在该位点的碱基替换为显性突变,可以影响植 株生长高度。通过对SLR1的T0代植株的观察发现,SLR1敲除植株的植株茎叶纤细,而发生碱基替换的转基因植株的植株高度明显矮于野生型的T0代植株,呈现又矮又壮的表型(图5D)。这些结果进一步证明了,应用本发明,在该位点成功进行了定点碱基替换,并且替换效率很高。According to previous studies, the base of the SLR1 gene at this site was replaced by a dominant mutation, which could affect the planting. Plant growth height. By observing the T0 generation plants of SLR1, it was found that the stems and leaves of SLR1 knockout plants were slender, and the transgenic plants with base substitutions were significantly shorter than the wild-type T0 plants, showing a short and strong phenotype. (Fig. 5D). These results further demonstrate that, with the application of the present invention, fixed-point base substitutions have been successfully performed at this site, and the substitution efficiency is high.
在该实施例中,我们只采取了常规的遗传转化工作,便获得了定点碱基替换的植株,说明本发明在植物研究和育种中广泛推广和应用的巨大潜力。In this example, we have only taken conventional genetic transformation work to obtain plants with fixed-point base substitutions, indicating the great potential of the present invention for widespread application and application in plant research and breeding.
并且,经过大量实验发现,动物启动子不能对本发明的植物(如水稻)进行定点碱基替换,只有本发明的植物启动子(尤其是水稻特异性的强启动子)才可对本发明的植物(如水稻)进行定点碱基替换,并且碱基替换效率可达11.5%,并且在一个突变植株内,有高达60%的细胞发生了碱基替换。Moreover, it has been found through extensive experiments that the animal promoter cannot perform site-based base substitution on the plant of the present invention (such as rice), and only the plant promoter of the present invention (especially a rice-specific strong promoter) can be used for the plant of the present invention ( For example, rice) performs site-based base substitution, and the base substitution efficiency is up to 11.5%, and up to 60% of cells in a mutant plant have base substitutions.
在本发明提及的所有文献都在本申请中引用作为参考,就如同每一篇文献被单独引用作为参考那样。此外应理解,在阅读了本发明的上述讲授内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。All documents mentioned in the present application are hereby incorporated by reference in their entirety in their entireties in the the the the the the the the In addition, it should be understood that various modifications and changes may be made by those skilled in the art in the form of the appended claims.
参考文献references
1 Carroll,D.Genome engineering with zinc-finger nucleases.Genetics 188,773-782,doi:10.1534/genetics.111.131433(2011).1 Carroll, D. Genome engineering with zinc-finger nucleases. Genetics 188, 773-782, doi: 10.1534/genetics. 111.131433 (2011).
2 Cong,L.et al.Multiplex genome engineering using CRISPR/Cas systems.Science 339,819-823,doi:10.1126/science.1231143(2013).2 Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823, doi: 10.1126/science.1231143 (2013).
3 Mahfouz,M.M.et al.De novo-engineered transcription activator-like effector(TALE)hybrid nuclease with novel DNA binding specificity creates double-strand breaks.Proceedings of the National Academy of Sciences of the United States of America 108,2623-2628,doi:10.1073/pnas.1019533108(2011).3 Mahfouz, MMet al. De novo-engineered transcription activator-like effector (TALE)hybrid nuclease with novel DNA binding specificity creates double-strand breaks.Proceedings of the National Academy of Sciences of the United States of America 108,2623-2628 , doi: 10.1073/pnas.1019533108 (2011).
4 Hsu,P.D.,Lander,E.S.&Zhang,F.Development and Applications of CRISPR-Cas9 for Genome Engineering.Cell 157,1262-1278,doi:10.1016/j.cell.2014.05.010(2014).4 Hsu, P.D., Lander, E.S. & Zhang, F. Development and Applications of CRISPR-Cas9 for Genome Engineering. Cell 157, 1262-1278, doi: 10.1016/j.cell.2014.05.010 (2014).
5 Mao,Y.et al.Application of the CRISPR-Cas System for Efficient Genome Engineering in Plants.Molecular plant,doi:10.1093/mp/sst121(2013).5 Mao, Y. et al. Application of the CRISPR-Cas System for Efficient Genome Engineering in Plants. Molecular plant, doi: 10.1093/mp/sst121 (2013).
6 Li,J.F.et al.Multiplex and homologous recombination-mediated genome  editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nature biotechnology 31,688-691, doi:10.1038/nbt.2654 (2013) .6 Li,J.F.et al.Multiplex and homologous recombination-mediated genome Editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nature biotechnology 31,688-691, doi:10.1038/nbt.2654 (2013) .
7 Shukla, V.K.et al. Precise genome modification in the crop species Zea mays using zinc-finger nucleases.Nature 459,437-441,doi:10.1038/nature07992 (2009).7 Shukla, V.K. et al. Precise genome modification in the crop species Zea mays using zinc-finger nucleases.Nature 459,437-441, doi:10.1038/nature07992 (2009).
8 Sun, Y.et al.Engineering Herbicide-Resistant Rice Plants through CRISPR/Cas9-Mediated Homologous Recombination of Acetolactate Synthase. Molecular plant 9,628-631,doi:10.1016/j.molp.2016.01.001 (2016) .8 Sun, Y. et al. Engineering Herbicide-Resistant Rice Plants through CRISPR/Cas9-Mediated Homologous Recombination of Acetolactate Synthase. Molecular plant 9,628-631, doi:10.1016/j.molp.2016.01.001 (2016) .
9 Huang,X.et al. Genomic architecture of heterosis for yield traits in rice.Nature 537,629-633,doi:10.1038/nature19760(2016).9 Huang, X. et al. Genomic architecture of heterosis for yield traits in rice. Nature 537, 629-633, doi: 10.1038/nature19760 (2016).
10 Huang,X.et al.Genome-wide association studies of 14 agronomic traits in rice landraces.Nature genetics 42,961-967,doi:10.1038/ng.695(2010). 10 Huang, X. et al. Genome-wide association studies of 14 agronomic traits in rice landraces. Nature genetics 42,961-967, doi: 10.1038/ng.695 (2010).
Figure PCTCN2017077133-appb-000008
Figure PCTCN2017077133-appb-000008

Claims (8)

  1. B结构:B structure:
    Y1-Y2-Y3   (B)Y1-Y2-Y3 (B)
    式中,In the formula,
    Y1为植物启动子,优选UBI、CaMV35S、Actin启动子;Y1 is a plant promoter, preferably UBI, CaMV35S, Actin promoter;
    Y2为融合蛋白的编码序列,所述融合蛋白具有如上所述的式Ia或Ib结构;Y2 is the coding sequence of a fusion protein having the structure of formula Ia or Ib as described above;
    Y3为终止子。Y3 is a terminator.
  2. 一种表达载体,其特征在于,所述表达载体含有如权利要求1所述的核酸构建物,其中,所述的第一表达盒、第二表达盒、和第三表达盒各自独立地位于相同或不同的载体上。An expression vector comprising the nucleic acid construct of claim 1, wherein the first expression cassette, the second expression cassette, and the third expression cassette are each independently located in the same Or on different carriers.
  3. 一种宿主细胞,其特征在于,所述细胞含有权利要求4所述的表达载体。A host cell comprising the expression vector of claim 4.
  4. 一种基因工程细胞,其特征在于,所述的细胞含有权利要求1所述的构建物,或其基因组整合有一个或多个权利要求1所述的构建物。A genetically engineered cell, characterized in that the cell comprises the construct of claim 1, or the genome thereof is integrated with one or more of the construct of claim 1.
  5. 一种对植物进行基因编辑的方法,其特征在于,包括步骤:A method for genetically editing a plant, comprising the steps of:
    (i)提供待编辑植物;(i) providing the plant to be edited;
    (ii)将权利要求4所述的表达载体导入所述待编辑植物。(ii) introducing the expression vector of claim 4 into the plant to be edited.
  6. 一种制备转基因植物细胞的方法,其特征在于,包括步骤:A method for preparing a transgenic plant cell, comprising the steps of:
    (i)将权利要求1所述的构建物、或权利要求4所述的载体转染植物细胞,使得所述构建物与所述植物细胞中的染色体发生定点突变,从而制得所述转基因植物细胞。(i) transducing the construct of claim 1 or the vector of claim 4 into a plant cell such that the construct and site-directed mutagenesis of the chromosome in the plant cell produce the transgenic plant cell.
  7. 一种制备转基因植物细胞的方法,其特征在于,包括步骤:A method for preparing a transgenic plant cell, comprising the steps of:
    (i)将权利要求1所述的构建物、或权利要求4所述的载体转染植物细胞,使得所述植物细胞含有所述构建物,从而制得所述转基因植物细胞。(i) transducing the construct of claim 1 or the vector of claim 4 to a plant cell such that the plant cell contains the construct, thereby producing the transgenic plant cell.
  8. 一种制备转基因植物的方法,其特征在于,包括步骤:A method for preparing a transgenic plant, comprising the steps of:
    将权利要求8或9所述方法制备的所述转基因植物细胞再生为植物体,从而获得所述转基因植物。 The transgenic plant cell prepared by the method of claim 8 or 9 is regenerated into a plant body to obtain the transgenic plant.
PCT/CN2017/077133 2016-12-02 2017-03-17 Vector for plant genome site-directed base substitution WO2018098935A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611180376.0A CN106609282A (en) 2016-12-02 2016-12-02 Carrier for base substitution of specific sites of plant genome
CN201611180376.0 2016-12-02

Publications (1)

Publication Number Publication Date
WO2018098935A1 true WO2018098935A1 (en) 2018-06-07

Family

ID=58635964

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/077133 WO2018098935A1 (en) 2016-12-02 2017-03-17 Vector for plant genome site-directed base substitution

Country Status (2)

Country Link
CN (1) CN106609282A (en)
WO (1) WO2018098935A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11447785B2 (en) 2016-11-14 2022-09-20 Institute of Genetics and Developmental Biology, Chinese Academv of Sciences Method for base editing in plants

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107043779B (en) * 2016-12-01 2020-05-12 中国农业科学院作物科学研究所 Application of CRISPR/nCas 9-mediated site-specific base substitution in plants
WO2019154285A1 (en) * 2018-02-08 2019-08-15 中国科学院上海生命科学研究院 No-label reagent combination for gene editing, and application thereof
WO2019153902A1 (en) * 2018-02-11 2019-08-15 中国科学院上海生命科学研究院 Plant genome site-directed substitution method
WO2020177751A1 (en) * 2019-03-06 2020-09-10 山东舜丰生物科技有限公司 Nucleic acid construct for gene editing
CN110527695B (en) * 2019-03-07 2020-06-16 山东舜丰生物科技有限公司 Nucleic acid construct for gene site-directed mutagenesis
CN111304180B (en) * 2019-06-04 2023-05-26 山东舜丰生物科技有限公司 Novel DNA nucleic acid cutting enzyme and application thereof
CN113774082A (en) * 2020-05-22 2021-12-10 山东舜丰生物科技有限公司 Method for expressing nucleic acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105934516A (en) * 2013-12-12 2016-09-07 哈佛大学的校长及成员们 CAS variants for gene editing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103290008B (en) * 2012-02-24 2016-09-14 中国科学院上海生命科学研究院 A kind of Plant overground part specific promoter and application thereof
WO2015007194A1 (en) * 2013-07-16 2015-01-22 中国科学院上海生命科学研究院 Method for plant genome site-directed modification
CN105992634B (en) * 2013-08-30 2019-06-14 华盛顿大学商业中心 Selective modification polymer subunits are to improve the analysis based on nano-pore

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105934516A (en) * 2013-12-12 2016-09-07 哈佛大学的校长及成员们 CAS variants for gene editing

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ALEXIS C. KOMOR: "Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage", NATURE, vol. 533, no. 7603, 20 April 2016 (2016-04-20), pages 420 - 424, XP055548777, ISSN: 1476-4687, DOI: doi:10.1038/nature17946 *
BRIAN S. PLOSKY: "CRISPR-Mediated Base Editing without DNA Double-Strand Breaks", MOLECULAR CELL, vol. 62, no. 4, 19 May 2016 (2016-05-19), pages 477 - 478, XP029552452, ISSN: 1097-2765, DOI: doi:10.1016/j.molcel.2016.05.006 *
YUAN ZONG: "Precise base editing in rice, wheat and maize with a Cas9- cytidine deaminase fusion", NATURE BIOTECHNOLOGY, vol. 35, no. 5, 27 February 2017 (2017-02-27), pages 1 - 5, XP055482699, ISSN: 1546-1696 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11447785B2 (en) 2016-11-14 2022-09-20 Institute of Genetics and Developmental Biology, Chinese Academv of Sciences Method for base editing in plants

Also Published As

Publication number Publication date
CN106609282A (en) 2017-05-03

Similar Documents

Publication Publication Date Title
WO2018098935A1 (en) Vector for plant genome site-directed base substitution
US11447785B2 (en) Method for base editing in plants
CN107027313B (en) Methods and compositions for multiplex RNA-guided genome editing and other RNA techniques
US10487336B2 (en) Methods for selecting plants after genome editing
WO2018202199A1 (en) Methods for isolating cells without the use of transgenic marker sequences
CN110157726B (en) Method for site-directed substitution of plant genome
US20210403901A1 (en) Targeted mutagenesis using base editors
Wu et al. Increasing cytosine base editing scope and efficiency with engineered Cas9-PmCDA1 fusions and the modified sgRNA in rice
Xu et al. Progresses, challenges, and prospects of genome editing in soybean (Glycine max)
CN104293828A (en) Site-specific modification method for plant genome
Lin et al. Genome editing in plants with MAD7 nuclease
CN110526993B (en) Nucleic acid construct for gene editing
WO2019205939A1 (en) Repeat-mediated plant site-specific recombination method
Huang et al. Base editors for citrus gene editing
JP2022511508A (en) Gene silencing by genome editing
AU2016222874A1 (en) Haploid induction
US20210087557A1 (en) Methods and compositions for targeted genomic insertion
Ali et al. Breakthrough in CRISPR/Cas system: Current and future directions and challenges
AU2018263195B2 (en) Methods for isolating cells without the use of transgenic marker sequences
Khan et al. Genome editing in cotton: challenges and opportunities
CN110951743B (en) Method for improving plant gene replacement efficiency
Neelakandan et al. Base editing in peanut using CRISPR/nCas9
JP2022549430A (en) Methods and compositions for DNA base editing
CN112522299A (en) Method for obtaining rice with increased tillering by using OsTNC1 gene mutation
US20230272408A1 (en) Plastid transformation by complementation of plastid mutations

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17876445

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 30/10/2019)

122 Ep: pct application non-entry in european phase

Ref document number: 17876445

Country of ref document: EP

Kind code of ref document: A1